An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy

被引：0
|
作者：
Sternberg, Anna R. [1 ,2 ]
Davidson, Robert J. [1 ]
Wilhelm, Amelia R. [1 ]
George, Lindsey A. [1 ,2 ]
机构：
[1] CHOP, Philadelphia, PA USA
[2] UPENN, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
697
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [1] A Novel Factor VIII Variant with Enhanced Secretion for Gene Therapy of Hemophilia A
    Cao, Wenjing
    Dong, Biao
    Firrman, Jenni A.
    Moore, Andrea R.
    Wang, Qizhao
    Roberts, Sean A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2014, 22 : S176 - S176
  • [2] Enhanced factor VIII gene therapy for hemophilia a dogs with a novel Furin-evading factor VIII variant
    Siner, J., I
    Samelson-Jones, B.
    Crudele, J. M.
    Zhou, S.
    Merricks, E.
    Nichols, T.
    Camire, R. M.
    Arruda, V. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 43 - 43
  • [3] Enhanced Factor VIII Heavy Chain for Gene Therapy of Hemophilia A
    Chen, Lingxia
    Lu, Hui
    Wang, Jinhui
    Sarkar, Rita
    Yang, Xiao
    Wang, Hongli
    High, Katherine A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2009, 17 (03) : 417 - 424
  • [4] Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice
    Sternberg, Anna R.
    Martos-Rus, Cristina
    Davidson, Robert J.
    Liu, Xueyuan
    George, Lindsey A.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] Variant of intron 22 inversions in the factor VIII gene in severe hemophilia A
    Yamazaki, E
    Mohri, H
    Inaba, H
    Harano, H
    Kanamori, H
    Okubo, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (07) : 445 - 449
  • [6] Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
    Lytle, Allison M.
    Brown, Harrison C.
    Spencer, H. Trent
    Doering, Christopher B.
    MOLECULAR THERAPY, 2015, 23 : S95 - S96
  • [7] Acquired hemophilia a hemostatic treatment with recombinant porcine factor VIII
    Sobolewska, A.
    Urbanska, A.
    Bednarska, M.
    Zawadzka, I.
    Witkowski, M.
    CLINICA CHIMICA ACTA, 2024, 558
  • [8] The Factor VIII Variant X5 Enhances Hemophilia a Gene Therapy Efficiency By Its Improved Secretion
    Horling, Franziska
    Lengler, Johannes
    Cao, Wenjing
    Dong, Biao
    Gangadharan, Bagirath
    De La Rosa, Maurus
    Hoellriegl, Werner
    Reipert, Birgit M.
    Scheiflinger, Friedrich
    Xiao, Weidong
    Rottensteiner, Hanspeter
    BLOOD, 2019, 134
  • [9] Transduction of modified factor VIII gene improves lentiviral gene therapy efficacy for hemophilia A
    Gong, Jie
    Chung, Tsai-Hua
    Zheng, Jie
    Zheng, Huyong
    Chang, Lung-Ji
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (06)
  • [10] FACTOR-VIII GENE AND HEMOPHILIA-A
    WHITE, GC
    SHOEMAKER, CB
    BLOOD, 1989, 73 (01) : 1 - 12
12345